Showing results (21-30 of 96) with videos related to
Sort By:
Pageof 10
The American Journal of Cardiology|June 24, 2008
Biologic activity of carotenoids related to distinct membrane physicochemical interactionsHyesun McNulty, Robert F Jacob, R Preston MasonCoronary Artery Disease|July 9, 2004
The antioxidant effects of statinsJean Davignon, Robert F Jacob, R Preston MasonCurrent Cardiology Reports|September 3, 2010
Advances in pharmacologic modulation of nitric oxide in hypertensionYoshiko Mizuno, Robert F Jacob, R Preston MasonAmerican Journal of Hypertension|August 30, 2008
Effects of calcium channel and renin-angiotensin system blockade on intravascular and neurohormonal mechanisms of hypertensive vascular diseaseYoshiko Mizuno, Robert F Jacob, R Preston MasonArteriosclerosis, Thrombosis, and Vascular Biology|March 28, 2020
Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic AcidR Preston Mason, Peter Libby, Deepak L BhattJournal of Atherosclerosis and Thrombosis|March 24, 2011
Inflammation and the development of atherosclerosisYoshiko Mizuno, Robert Francis Jacob, R Preston MasonExpert Opinion on Drug Safety|July 13, 2021
Icosapent ethyl: safely reducing cardiovascular risk in adults with elevated triglyceridesManan Pareek, R Preston Mason, Deepak L BhattCardiorenal Medicine|January 19, 2018
Eicosapentaenoic Acid as a Potential Therapeutic Approach to Reduce Cardiovascular Risk in Patients with End-Stage Renal Disease on Hemodialysis: A ReviewKenneth M Borow, R Preston Mason, Krishnaswami VijayaraghavanJournal of Cardiovascular Pharmacology|June 17, 2009
Evolving mechanisms of action of beta blockers: focus on nebivololR Preston Mason, Thomas D Giles, James R SowersAtherosclerosis|August 9, 2015
Biologic plausibility, cellular effects, and molecular mechanisms of eicosapentaenoic acid (EPA) in atherosclerosisKenneth M Borow, John R Nelson, R Preston MasonPageof 10